blood glucose regulation critically ill patients
Conditions
Interventions
13-aug-2012:
The OptiScanner is a point of care device for measurement of blood glucose as well as other analytes. It works by measuring the optical infrared absorption of glucose in a very small amou
Sponsors
Academic Medical Center
Meibergdreef 9
1105 AZ Amsterdam
The Netherlands
OptiScan Biomedical Corporation
Hayward (CA)
United States of America
Eligibility
Inclusion criteria
Inclusion criteria: 1. Signed Informed consent; 2. Age ≥ 18 years; 3. Admitted to the ICU of the Academic Medical Center or Gelre Hospitals Apeldoorn; 4. Expected ICU stay of ≥ 3 days at the time of enrollment (as judged by Principle Investigators); 5. APACHE II score of ≥ 10, within the first 24 hours of ICU admission; 6. Existing central venous catheter + arterial catheter; 7. No participation in any other investigational interventional study while enrolled in this study.
Exclusion criteria
Exclusion criteria: 1. Have received any investigational product or been treated with an investigational device within the past 30 days; 2. Pregnancy; 3. Untreatable colonization with multi–resistant bacteria (e.g. methicillin–resistant Staphylococcus aureus).
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| 13-aug-2012: 1. Glucose prediction error, defined as the results of the OptiScanner, versus the RAPIDlab, using arterial blood; 2. Clarke Error Grid analysis showing the percentage of paired data values falling within each zone between the results of the OptiScanner versus the RAPIDlab, using arterial blood; 3. Linearity between the results of the OptiScanner versus the RAPIDlab, using arterial blood. | — |
Primary
| Measure | Time frame |
|---|---|
| 13-aug-2012: 1. Glucose prediction error, defined as the results of the YSI versus the OptiScanner, using arterial blood; 2. Clarke Error Grid analysis showing the percentage of paired data values falling within each zone between the results of the YSI versus the OptiScanner, using arterial blood; 3. Linearity between the results of the YSI versus the OptiScanner, using arterial blood. | — |
Contacts
Public ContactM.J. Schultz
Meibergdreef 9
Outcome results
None listed